Virtu Financial’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-118,329
Closed -$661K 1630
2025
Q3
$661K Buy
+118,329
New +$512K 0.04% 456
2025
Q2
Sell
-20,075
Closed -$58K 1428
2025
Q1
$58K Buy
+20,075
New +$60.8K ﹤0.01% 991
2024
Q4
Sell
-22,986
Closed -$114K 1522
2024
Q3
$114K Sell
22,986
-14,915
-39% -$58K 0.01% 884
2024
Q2
$99K Sell
37,901
-64,935
-63% -$217K 0.01% 829
2024
Q1
$438K Buy
102,836
+70,666
+220% +$235K 0.03% 459
2023
Q4
$65K Buy
+32,170
New +$56.8K 0.01% 1128
2023
Q2
Sell
-12,884
Closed -$15K 1489
2023
Q1
$15K Buy
+12,884
New +$11.2K ﹤0.01% 1298
2022
Q3
Sell
-106,408
Closed -$68K 1702
2022
Q2
$68K Buy
106,408
+95,693
+893% +$127K 0.01% 1034
2022
Q1
$28K Sell
10,715
-68,423
-86% -$200K ﹤0.01% 1248
2021
Q4
$308K Buy
+79,138
New +$397K 0.03% 598
2021
Q3
Sell
-18,521
Closed -$74K 1475
2021
Q2
$74K Buy
+18,521
New +$74K 0.01% 1265
2021
Q1
Sell
-59,050
Closed -$316K 1574
2020
Q4
$316K Sell
59,050
-58,156
-50% -$349K 0.03% 618
2020
Q3
$569K Buy
117,206
+106,273
+972% +$695K 0.1% 255
2020
Q2
$53K Buy
+10,933
New +$50.3K 0.01% 997

Other funds holding AQST

Virtu Financial's AQST Position: Q4 2025 in Review

Virtu Financial sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 118,329 shares — an estimated $661K sold.

Virtu Financial first reported a position in AQST in Q2 2020 and held it in 14 quarters. The position peaked at $661K in Q3 2025. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • Virtu Financial reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 118,329 Aquestive Therapeutics shares in Q4 2025, an estimated $661K.
  • Virtu Financial first reported a position in Aquestive Therapeutics in Q2 2020 and held it in 14 quarters.
  • Virtu Financial's Aquestive Therapeutics position peaked at $661K in Q3 2025.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.